Cataract Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

11:42 EDT 5 Aug 2017 | BioPortfolio Reports

DelveInsight's, Cataract Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Cataract. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Cataract. This report provides information on the therapeutic development for Cataract, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, preclinical as well as discovery products. The report further contains details on dormant products and discontinued products. Therapeutic assessment of all the active products by route of administration and molecule type is also covered in this report.
The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Regeneron PharmaceuticalsOmerosDomp FarmaceuticiLenstec IncorporatedSintesi Research Ivantis Inc.Glaukos Corporation Acucela Inc
EyeGate Pharmaceuticals Inc
Genisphere LLC
Johnson Johnson
Omeros Corp
Plex Pharmaceuticals Inc
Cataract Pipeline Drugs
Cataract Pipeline Assessment
Cataract Pipeline Analysis
Cataract Drugs under Development
Cataract Discovery drugs
Cataract Preclinical drugs
Cataract Phase I drugs
Cataract Phase II drugs
Cataract Phase III Pipeline Drugs Assessment
Cataract Preregistration drugs
Cataract Molecules in pipeline

Original Article: Cataract Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250


More From BioPortfolio on "Cataract Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250"

Quick Search

Relevant Topics

Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...